SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes inspection at Indoco Remedies’ Kilo Lab facility, IAS division

16 May 2024 Evaluate

United States Food and Drug Administration (USFDA) has successfully completed inspection at Indoco Remedies’ API Kilo Lab Manufacturing facility (Kilo Lab) located at Rabale, Navi Mumbai (Facility) and Indoco Analytical Solutions (IAS) Division. The inspection concluded with zero Form 483 observations, reflecting the company's commitment to maintaining the highest standards of quality and compliance.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.


Indoco Remedies Share Price

220.00 2.75 (1.27%)
17-Apr-2026 12:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1676.00
Dr. Reddys Lab 1230.40
Cipla 1239.35
Zydus Lifesciences 944.45
Lupin 2310.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×